Cream tested to restore skin color in sensitive areas
NCT ID NCT05750823
Summary
This study tested a cream called ruxolitinib for people with vitiligo affecting their genital area. Forty-nine participants applied the cream twice daily for up to 48 weeks to see if it could help restore skin color and reduce the noticeability of the condition. Researchers measured how well the treatment worked and monitored for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONSEGMENTAL VITILIGO WITH GENITAL INVOLVEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Apex Clinical Research Center
Mayfield, Ohio, 44124, United States
-
Austin Institute For Clinical Research Aicr Pflugerville
Pflugerville, Texas, 78660, United States
-
Center For Dermatology Clinical Research, Inc
Fremont, California, 94538, United States
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, 33075, France
-
Chu Nice Hopital Archet 2
Nice, 06202, France
-
Dermatology Research Institute
Calgary, Alberta, T2J 7E1, Canada
-
Hamzavi Dermatology
Fort Gratiot, Michigan, 48059-3526, United States
-
Hopital Henri Mondor Service de Dermatologie
Créteil, 94000, France
-
Innovative Dermatology: Legacy Medical Village
Plano, Texas, 75024-4319, United States
-
Research Toronto
Toronto, Ontario, M3H 5Y8, Canada
-
Simcomed Health Ltd
Barrie, Ontario, L4M 7G1, Canada
-
Skin Centre For Dermatology
Peterborough, Ontario, K9J 5K2, Canada
-
Vitiligo & Pigmentation Institute of Southern California
Los Angeles, California, 90036, United States
Conditions
Explore the condition pages connected to this study.